Table 3. Antimicrobial resistance profiles of Shigella isolates in Xinjiang between 2008 and 2014.
| Antibiotic* | Number of isolates (%) | |
|---|---|---|
| S. flexneri (n = 365) | S. sonnei (n = 93) | |
| No resistance detected | 12 (3.3) | 3 (3.2) |
| Resistant ≥ 1 CLSI class | 353 (96.7) | 90 (96.8) |
| Resistant ≥ 2 CLSI classes | 349 (95.6) | 90 (96.8) |
| Resistant ≥ 3 CLSI classes | 330 (90.4) | 59 (63.4) |
| Resistant ≥ 4 CLSI classes | 200 (54.8) | 53 (57.0) |
| Resistant ≥ 5 CLSI classes | 62 (17.0) | 14 (15.1) |
| Resistant ≥ 6 CLSI classes | 21 (5.8) | 0 |
| Resistant = 7 CLSI classes | 8 (2.2) | 0 |
| Cephalosporin | 57 (15.6) | 18 (19.4) |
| Quinolones | 86 (23.6) | 0 |
| Cephalosporin and quinolones | 17 (4.7) | 0 |
| At least ACTT/S | 136 (37.3) | 0 |
| At least ACTT/SNOR | 38 (10.4) | 0 |
| At least ACTT/SCRO | 22 (6.0) | 0 |
| At least ACTT/SCRONOR | 9 (2.5) | 0 |
*A, ampicillin; C, chloramphenicol; CRO, ceftriaxone; NOR, norfloxacin; T, tetracycline; T/S, trimethoprim/sulfamethoxazole.